Potassium and Atrovent hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium (potassium) and Atrovent hfa (ipratropium bromide). Common drug interactions include nausea among females and blood creatine phosphokinase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium and Atrovent hfa. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.

What is Atrovent hfa?

Atrovent hfa has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 2,440 Atrovent hfa users. Check the latest studies of Atrovent hfa.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 18, 2026

61 people who take Potassium and Atrovent hfa together, and have interactions are studied.

Potassium and Atrovent hfa drug interactions.

What are the common drug interactions of Potassium and Atrovent Hfa, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Neoplasm (tumour)
Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)
Oxygen consumption decreased
Respiratory failure (inadequate gas exchange by the respiratory system)
Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
Stress
Stridor
Transferrin saturation decreased
Weight decreased

male:

Blood creatine phosphokinase increased
Fall
Cardiac disorder
Death
Decreased appetite
Dizziness
Dry skin
Dyspnoea (difficult or laboured respiration)
Epistaxis (bleed from the nose)
Fluid retention (an abnormal accumulation of fluid in the blood)

What are the common drug interactions of Potassium and Atrovent Hfa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Pneumonia
Pruritus (severe itching of the skin)
Rash
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Stomatitis (inflammation of mucous membrane of mouth)
Tinnitus (a ringing in the ears)
Urticaria (rash of round, red welts on the skin that itch intensely)
Vision blurred
Vomiting
Abdominal pain upper

60+:

Dyspnoea (difficult or laboured respiration)
Fall
Weight increased
Cough
Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Cerebral haemorrhage (bleeding within the brain)
Contusion (a type of hematoma of tissue in which capillaries)
Ear infection
Infection

What are the existing conditions these people have? *

Urinary Tract Infection: 24 people, 39.34%
Nausea And Vomiting: 21 people, 34.43%
Asthma: 21 people, 34.43%
Malaise (a feeling of general discomfort or uneasiness): 20 people, 32.79%
Depression: 20 people, 32.79%
Fluid Retention (an abnormal accumulation of fluid in the blood): 20 people, 32.79%
Hallucinations (sensations that appear real but are created by your mind): 20 people, 32.79%
Iron Deficiency: 20 people, 32.79%
Itching: 20 people, 32.79%
Urticaria (rash of round, red welts on the skin that itch intensely): 20 people, 32.79%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium and Atrovent hfa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously